AOD 9604 had six human trials and 900 participants. Phase IIa showed positive results. Then the pivotal Phase IIb failed at every dose tested. Development was terminated in 2007. The trial history is Peptides for Weight Loss NYC: GLP 1, CJC 1295, AOD 9604 Explained AOD 9604: Research in Tissue Biology and Mammalian Oncology AOD 9604: The most targeted fat loss peptide you've probably never heard of. This HGH fragment was literally engineered to burn fat without the blood sugar chaos that comes with full growth hormone.
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols